CTMX CytomX Therapeutics Inc.
NEUTRAL
Impact: 3/10
PRESS-RELEASE
Press release: earnings
Final — all horizons settled through T+60d
CTMX ▼ -26.82% at T+60d
NEUTRAL call ✗ call lost -26.82% · α vs SPY -36.91% · entry $5.07 → $3.71
Last close $3.01 (close Jun 12) · -40.63% from $5.07 entry
T+1d
-5.92%
call -5.92% · α -5.34%
$4.77
settled 3mo ago
T+5d
-3.75%
call -3.75% · α -2.41%
$4.88
settled 3mo ago
T+20d
-10.06%
call -10.06% · α -5.64%
$4.56
settled 3mo ago
T+60d
-26.82%
call -26.82% · α -36.91%
$3.71
settled 17d ago
Price Chart
Loading chart...
Executive Summary
CytomX Therapeutics announced it will report full year 2025 financial results on March 16, 2026, before markets open, followed by a conference call. The press release contains no financial data, forward-looking results, or operational updates beyond the announcement of the earnings event.
Actionable Insight
Traders should await the actual earnings release and call for material data. No trading action is warranted based on this announcement alone.
Key Facts
- CytomX Therapeutics (CTMX) will report full year 2025 financial results on March 16, 2026, before market open.
- Company will host a conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT on the same day.
- No financial results, guidance, or material operational updates were disclosed in this press release.
- The release serves solely as a scheduling announcement for upcoming earnings.
Financial Impact
No financial data disclosed
Risk Factors
- Earnings could miss expectations given lack of pre-announcement or positive signaling.
- Biotech stocks like CTMX often experience volatility around earnings, especially with no forward guidance provided.
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3249296 |
4 reports for CTMX
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Mar 18, 2026
12w ago
|
Press Release
| $4.40 $2.98 | ▼ −32.27% | ▼ −43.80% | $3.01 (−31.59%) |
|
Mar 16, 2026
12w ago
|
Press Release
| $5.45 $2.98 | ▲ +45.32% | ▲ +55.18% | $3.01 (+44.77%) |
|
Mar 16, 2026
12w ago
|
Press Release
| $6.75 $2.94 | ▼ −56.44% | ▼ −66.93% | $3.01 (−55.41%) |
|
Mar 4, 2026
14w ago
|
Press Release
| $5.07 $3.71 | ▼ −26.82% | ▼ −36.91% | $3.01 (−40.63%) |
Showing 4 of 4
US Market Status
Market Closed — Opens in 5h 5m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access